...
首页> 外文期刊>The journal of immunology >High Frequency of Cytolytic 21-Hydroxylase–Specific CD8+ T Cells in Autoimmune Addison’s Disease Patients
【24h】

High Frequency of Cytolytic 21-Hydroxylase–Specific CD8+ T Cells in Autoimmune Addison’s Disease Patients

机译:自身免疫性艾迪生病患者的细胞溶解性21-羟化酶特异性CD8 + T细胞频率高

获取原文
           

摘要

The mechanisms behind destruction of the adrenal glands in autoimmune Addison’s disease remain unclear. Autoantibodies against steroid 21-hydroxylase, an intracellular key enzyme of the adrenal cortex, are found in 90% of patients, but these autoantibodies are not thought to mediate the disease. In this article, we demonstrate highly frequent 21-hydroxylase–specific T cells detectable in 20 patients with Addison’s disease. Using overlapping 18-aa peptides spanning the full length of 21-hydroxylase, we identified immunodominant CD8+ and CD4+ T cell responses in a large proportion of Addison’s patients both ex vivo and after in vitro culture of PBLs ≤20 y after diagnosis. In a large proportion of patients, CD8+ and CD4+ 21-hydroxylase–specific T cells were very abundant and detectable in ex vivo assays. HLA class I tetramer–guided isolation of 21-hydroxylase–specific CD8+ T cells showed their ability to lyse 21-hydroxylase–positive target cells, consistent with a potential mechanism for disease pathogenesis. These data indicate that strong CTL responses to 21-hydroxylase often occur in vivo, and that reactive CTLs have substantial proliferative and cytolytic potential. These results have implications for earlier diagnosis of adrenal failure and ultimately a potential target for therapeutic intervention and induction of immunity against adrenal cortex cancer.
机译:自身免疫性艾迪生病中肾上腺破坏的机制尚不清楚。在超过90%的患者中发现了针对肾上腺皮质细胞内关键酶类固醇21-羟化酶的自身抗体,但据认为这些自身抗体不能介导该疾病。在本文中,我们证明了在20名患有艾迪生病的患者中可检测到的高频率21-羟化酶特异性T细胞。通过使用跨越21-羟化酶全长的18-aa重叠肽段,我们在离体和诊断后≤20 y的PBLs体外培养中,在大部分Addison患者中鉴定了免疫优势的CD8 +和CD4 + T细胞应答。在大多数患者中,CD8 +和CD4 + 21-羟化酶特异性T细胞非常丰富,在离体检测中可检测到。 HLA I类四聚体指导的21-羟化酶特异性CD8 + T细胞的分离显示了其裂解21-羟化酶阳性靶细胞的能力,与疾病发病机理的潜在机制一致。这些数据表明对21-羟化酶的强CTL反应通常在体内发生,并且反应性CTL具有实质性的增殖和细胞溶解潜力。这些结果对肾上腺衰竭的早期诊断有影响,并最终成为治疗干预和诱导针对肾上腺皮质癌的免疫力的潜在靶标。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号